Experimental Drug Reverses Hypertension Damage in Heart and Kidneys of Mice
What Happened
Researchers have reported promising results for an experimental drug called Compound17b (Cmpd17b), which targets inflammation pathways linked to high blood pressure. In hypertensive mice, the drug not only reduced blood pressure but also reduced kidney scarring, improved blood vessel function, and lowered damage to the heart and kidneys caused by long-term hypertension.
Key Takeaways
The study suggests that tackling inflammation, alongside controlling blood pressure, could offer a new way to repair organ damage caused by hypertension rather than simply slowing its progression.